Précisez une action ou une cryptomonnaie dans la barre de recherche pour obtenir un récapitulatif
Veru Inc
FMWVeru Inc., a late clinical stage biopharmaceutical company, focuses on developing medicines for treatment of metabolic diseases, oncology, and acute respiratory distress syndrome (ARDS). Its marketed products comprise FC2 female condom for the dual protection against unplanned pregnancy and the transmission of sexually transmitted infections. The company's development program includes enobosarm, a selective androgen receptor modulator for treatment of augment fat loss and to prevent muscle loss in sarcopenic obese and overweight elderly patients; Enobosarm, a selective androgen receptor modulator for the treatment of AR+ ER+ HER2- metastatic breast cancer; and sabizabulin, a microtubule disruptor for the treatment of hospitalized patients with viral lung infection on oxygen support who are at high risk for viral induced ARDS and death. The company was formerly known as The Female Health Company and changed its name to Veru Inc. in July 2017. Veru Inc. was incorporated in 1971 and is headquartered in Miami, Florida. Address: 2916 North Miami Avenue, Miami, FL, United States, 33127
Analytics
Objectif de Cours de WallStreet
3.4 USDRatio C/B
–Rendement du dividende
–Année actuelle
L'année dernière
Trimestre en cours
Le dernier trimestre
Année actuelle
L'année dernière
Trimestre en cours
Le dernier trimestre
Chiffres clés FMW
Analyse des dividendes FMW
Croissance des dividendes sur 5 ans
–Croissance continue
3 annéesRatio de distribution Moyenne sur 5 ans
–Historique des dividendes FMW
Valorisation des titres FMW
financières FMW
Résultats | 2019 | Dynamique |